Lynn A. Tetrault

This profile gathers the share dealings of Lynn A. Tetrault across 3 companies, led by Neogenomics Inc, Rhythm Pharmaceuticals, Inc. and Alumis Inc. Over a trading history stretching from 2 June 2021 to 30 June 2026, the count stands at 16 filings.

On the open market, the record shows 1 purchase worth €51k and 1 sale worth €90k. The net balance comes to €39k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 4 share grants and 10 option exercises.

The newest entry dates from 2 July 2026: a share grant, in Alumis Inc. The clock since the last published purchase (9 May 2025) now reads 527 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.